home / stock / lgndz / lgndz news
2024-05-07 23:03:10 ET Ligand Pharmaceuticals Incorporated (LGND) Q1 2024 Earnings Conference Call May 07, 2024 04:30 PM ET Company Participants Michael Jeong - Investor Relations Todd Davis - Chief Executive Officer Paul Hadden - Senior Vice President, Investmen...
2024-04-25 10:05:00 ET Summary Tourlite Capital Management, LP is an asset management firm focused on long/short equity investing in public companies. Tourlite Fund, LP returned 6.0% for the First Quarter of 2024. The Fund has annualized returns of 10.0% since inception, compa...
2023-11-15 13:22:59 ET Summary Ligand Pharmaceuticals Incorporated is a biopharma company focused on developing technologies for pharmaceutical companies. The company has a wide assortment of assets it draws royalty income from and an expanding pipeline. Ligand Pharmaceuticals...
2023-11-08 22:22:05 ET Ligand Pharmaceuticals Inc. (LGND) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Simon Latimer - Head-Investor Relations Todd Davis - Chief Executive Officer Matthew Korenberg - President and Chief Operat...
2023-08-08 22:52:07 ET Ligand Pharmaceuticals Incorporated (LGND) Q2 2023 Earnings Conference Call August 8, 2023 16:30 ET Company Participants Simon Latimer - Head, Investor Relations Todd Davis - Chief Executive Officer Tavo Espinoza - Chief Financial Officer ...
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharms Inc Cvr Company Name:
LGNDZ Stock Symbol:
OTCMKTS Market:
Ligand Pharms Inc Cvr Website: